Cardiac rhythm devices in the pediatric population: utilization and complications
- PMID: 21907171
- DOI: 10.1016/j.hrthm.2011.09.004
Cardiac rhythm devices in the pediatric population: utilization and complications
Abstract
Background: Cardiac rhythm devices are important in the management of pediatric patients with rhythm abnormalities, although factors driving utilization are poorly understood.
Objective: This study sought to evaluate utilization trends, complication rates, and cost associated with device implantation in the pediatric population.
Methods: Device implantation was analyzed using the Kids' Inpatient Database from 1997 to 2006. The type of device implantation, patient demographics, hospital characteristics, acute in-hospital complications, cost, and length of stay (LOS) were analyzed. χ(2) tests were used to test association between categorical variables, and logistic regression analysis was performed to evaluate risk factors associated with complications.
Results: There were 5788 hospitalizations with device implantations. Although there was a significant increase in defibrillator implantation, there was no significant increase in the number of pacemaker implantations over this time period. Patient- and device-related complications were relatively common in all device cohorts (pacemaker 11.2%, 7.2%; defibrillator 5.9%, 11.5%; and biventricular device 19.4%, 26.7%). Type of complication was dependent on device type. Increased risk of complication was evident in the pacemaker cohort, patients with congenital heart disease, cardiomyopathy, previous cardiac arrest, and other heart operations. Patient-related complications increased cost and LOS regardless of patient or procedural characteristics. Device implantation in patients <5 years old was associated with increased LOS and cost but was not associated with increased risk of complication.
Conclusion: Device utilization in pediatrics is increasing due to escalating defibrillator implantation and biventricular pacing. Cost and LOS are significantly increased by patient complications. Reduction in these complications would improve patient care and lower medical costs.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Comment in
-
Orbits and implants: trends in indications, utilization, and complications in pediatric device therapy.Heart Rhythm. 2012 Feb;9(2):209-10. doi: 10.1016/j.hrthm.2011.09.059. Epub 2011 Sep 23. Heart Rhythm. 2012. PMID: 21946340 No abstract available.
Similar articles
-
Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center TwoYear Survey.Hellenic J Cardiol. 2016 Jan-Feb;57(1):33-8. doi: 10.1016/s1109-9666(16)30016-1. Hellenic J Cardiol. 2016. PMID: 26856199
-
Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.Europace. 2013 Apr;15(4):531-40. doi: 10.1093/europace/eus337. Epub 2013 Feb 13. Europace. 2013. PMID: 23407627
-
Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21. Europace. 2015. PMID: 25336667
-
Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness.Annu Rev Med. 2017 Jan 14;68:1-13. doi: 10.1146/annurev-med-043015-123540. Epub 2016 Sep 21. Annu Rev Med. 2017. PMID: 27686020 Review.
-
Health economic concerns on cardiac rhythm management devices longevity and how to overcome them.Expert Rev Med Devices. 2016;13(3):297-303. doi: 10.1586/17434440.2016.1142871. Epub 2016 Feb 24. Expert Rev Med Devices. 2016. PMID: 26778415 Review.
Cited by
-
Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention.Europace. 2024 Aug 30;26(9):euae245. doi: 10.1093/europace/euae245. Europace. 2024. PMID: 39345160 Free PMC article.
-
Cost of Pacing in Pediatric Patients With Postoperative Heart Block After Congenital Heart Surgery.JAMA Netw Open. 2023 Nov 1;6(11):e2341174. doi: 10.1001/jamanetworkopen.2023.41174. JAMA Netw Open. 2023. PMID: 37921766 Free PMC article.
-
Transvenous lead extraction in children with bidirectional rotational dissection sheaths.Front Cardiovasc Med. 2023 Sep 8;10:1256752. doi: 10.3389/fcvm.2023.1256752. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745106 Free PMC article.
-
The role of cardiac anaesthesiologists in placing a temporary transvenous endocardial lead in the operation room during pulse generator replacement in a child with congenital complete heart block.Ann Card Anaesth. 2023 Jul-Sep;26(3):362-363. doi: 10.4103/aca.aca_173_22. Ann Card Anaesth. 2023. PMID: 37470547 Free PMC article. No abstract available.
-
Epicardial vs. transvenous implantable cardioverter defibrillators in children.Europace. 2023 Mar 30;25(3):961-968. doi: 10.1093/europace/euad015. Europace. 2023. PMID: 36735263 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
